DEL PAPA, BEATRICE
 Distribuzione geografica
Continente #
NA - Nord America 2.248
EU - Europa 1.633
AS - Asia 1.455
SA - Sud America 233
Continente sconosciuto - Info sul continente non disponibili 151
AF - Africa 47
OC - Oceania 1
Totale 5.768
Nazione #
US - Stati Uniti d'America 2.185
SG - Singapore 656
IT - Italia 390
IE - Irlanda 292
CN - Cina 273
BR - Brasile 178
DE - Germania 176
HK - Hong Kong 160
RU - Federazione Russa 154
VN - Vietnam 146
FI - Finlandia 110
SE - Svezia 105
UA - Ucraina 102
FR - Francia 85
GB - Regno Unito 73
KR - Corea 52
IN - India 46
RO - Romania 40
CA - Canada 33
BD - Bangladesh 24
TR - Turchia 24
BE - Belgio 22
MX - Messico 20
CZ - Repubblica Ceca 18
AR - Argentina 16
AT - Austria 14
PL - Polonia 13
UZ - Uzbekistan 13
EC - Ecuador 12
CO - Colombia 9
JP - Giappone 9
MA - Marocco 9
ES - Italia 8
ET - Etiopia 8
IQ - Iraq 8
LT - Lituania 7
PH - Filippine 7
PK - Pakistan 7
ZA - Sudafrica 7
CH - Svizzera 6
VE - Venezuela 6
CI - Costa d'Avorio 5
EG - Egitto 5
NL - Olanda 5
CL - Cile 4
KE - Kenya 4
AZ - Azerbaigian 3
GR - Grecia 3
ID - Indonesia 3
LB - Libano 3
MY - Malesia 3
NP - Nepal 3
PE - Perù 3
SA - Arabia Saudita 3
TN - Tunisia 3
BG - Bulgaria 2
BO - Bolivia 2
CR - Costa Rica 2
HR - Croazia 2
KZ - Kazakistan 2
NI - Nicaragua 2
PT - Portogallo 2
QA - Qatar 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
IL - Israele 1
IM - Isola di Man 1
JM - Giamaica 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MM - Myanmar 1
OM - Oman 1
PR - Porto Rico 1
PY - Paraguay 1
RE - Reunion 1
SC - Seychelles 1
SI - Slovenia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
YT - Mayotte 1
Totale 5.618
Città #
Singapore 484
Chandler 294
Dublin 292
San Jose 213
San Mateo 193
Perugia 188
Hong Kong 160
Ashburn 139
Boardman 80
Beijing 76
Santa Clara 76
Ann Arbor 70
Munich 66
Jacksonville 55
Seoul 52
Dong Ket 51
New York 51
Altamura 48
Lauterbourg 47
Los Angeles 47
Medford 46
Princeton 45
Moscow 43
Helsinki 41
Bucharest 40
Andover 38
Turku 37
Wilmington 36
Lawrence 35
Foligno 33
Ho Chi Minh City 29
Brussels 22
Council Bluffs 21
Dearborn 21
Hanoi 21
Redwood City 19
São Paulo 19
Piscataway 18
The Dalles 16
Houston 15
Dallas 14
Des Moines 13
London 13
Brno 12
Norwalk 12
Assisi 11
Brooklyn 11
Izmir 11
Toronto 11
Shanghai 10
Woodbridge 10
Frankfurt am Main 9
Rio de Janeiro 9
Tokyo 9
Vienna 9
Atlanta 8
Barnet 8
Chicago 8
Falls Church 8
Orem 8
Saint Petersburg 8
San Paolo di Civitate 8
Warsaw 8
Addis Ababa 7
Belo Horizonte 7
Boston 7
Charlotte 7
Hefei 7
Mexico City 7
Montreal 7
Quito 7
San Francisco 7
Stockholm 7
Tashkent 7
Buffalo 6
Chennai 6
Da Nang 6
Denver 6
Falkenstein 6
Mumbai 6
Abidjan 5
Ankara 5
Guangzhou 5
Rome 5
Bastia 4
Caracas 4
Casablanca 4
Changsha 4
Madrid 4
Milan 4
Nuremberg 4
Ottawa 4
Redmond 4
Amsterdam 3
Aurora 3
Baghdad 3
Biên Hòa 3
Bologna 3
Buenos Aires 3
Cairo 3
Totale 3.695
Nome #
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia 183
Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation. 180
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment. 173
Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction 158
Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo. 155
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment in vitro and supports immunologic reconstitution after HSCT in NOD/SCID mice 146
Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL 138
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia 134
GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutations 132
NOTCH1 Aberrations in Chronic Lymphocytic Leukemia. 131
Mesenchymal cells: a vehicle for gene therapy 127
NPM1 AND FLT3-ITD MUTATIONS SINERGISTICALLY INDUCE GATA1 EPIGENETIC SILENCING IN A AML MOUSE MODEL 126
Clinical-Grade Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell Dependent Graft-versus-Leukemia Effect in Murine Models 124
γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and Notch down-regulation. 122
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 122
Chronic myeloproliferative disorders: the bone marrow stromal component is not involved in the malignant clone.Di Ianni M, Moretti L, Del Papa B, De Ioanni M, Bonifacio E, Falzetti F, Tabilio A. 122
Engineering mesenchymal cells with interleukin 7 gene: effects on T cell. 18-23. 119
Human stromal cells engineered with interleukin-7 enhance the survival of naive T lymphocytes. 118
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 118
NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells. 118
IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation. 116
T regulatory cell separation for clinical application. 113
Clinical-Grade Expanded Regulatory T Cells Are Enriched with Highly Suppressive Cells Producing IL-10, Granzyme B, and IL-35 111
Ibrutinib treatment of a patient with relapsing chronic lymphocytic leukemia and sustained remission of Richter syndrome 110
A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia 110
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 109
NPM1 AND FLT3-ITD MUTATIONS COOPERATE TO IMPAIR HEMATOPOIETIC STEM/PROGENITOR CELLS DIFFERENTIATION AND DEREGULATE GATA1 IN A MOUSE MODEL OF AML 109
A novel NOTCH1 PEST domain mutation in a case of Chronic Lymphocytic Leukemia 107
Interleukin-7-engineered mesenchymal cells: in vitro effects on naive T-cell population. 106
A microelectronic DNA chip detects the V617F JAK-2 mutation in myeloproliferative disorders 103
CURCUMIN EXHIBITS IN VITRO AND IN VIVO ANTI-LEUKEMIC ACTIVITY INTERFERING WITH THE NOTCH1 PATHWAY AND INDUCING ENDOPLASMIC RETICULUM STRESS IN CHRONIC LYMPHOCYTIC LEUKEMIA 102
IN VITRO AND IN VIVO ANTILEUKEMIC ACTIVITY OF BEPRIDIL IN CHRONIC LYMPHOCYTIC LEUKEMIA IS ASSOCIATED WITH INHIBITION OF THE NOTCH1 PATHWAY 100
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 98
Exploring the radiosensitizing potential of AZD8931: a pilot study on the human LoVo colorectal cancer cell line 97
NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL. 96
BEPRIDIL IS A POTENT NOTCH1 INHIBITOR AND EFFICIENTLY INDUCES APOPTOSIS IN CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) CELLS in vitro AND in vivo 95
A NOVEL MECHANISM FOR NOTCH1 ACTIVATIONIN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS: INVOLVEMENT OF NOTCH1 ENDOSOMAL TRAFFICKING AND ALTERATIONS IN RAB PROTEINS 93
Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia 89
Interleukin 7-engineered stromal cells: a new approach for hastening naive T cell recruitment 89
Transformation by retroviral vectors of bone marrow-derived mesenchymal cells induces mitochondria-dependent cAMP-sensitive reactive oxygen species production. 89
NOTCH and NF-κB interplay in chronic lymphocytic leukemia is independent of genetic lesion. 89
New mechanism of lymphoma-induced bone marrow aplasia 89
Mesenchymal cells recruit and regulate T regulatory cells. 85
Immunomagnetic isolation of CD4+CD25+FoxP3+ natural T regulatory lymphocytes for clinical applications. 85
Catalase prevents DNA damage and cationic current activation by silver nanoparticles in U251 human glioblastoma cell line 82
IL-7 engineered donor stromal cells in vitro: a new approach for hastening naive T cell recruitment. 80
A DYSREGULATED, DRUGGABLE PP2A/AKT/GSK3 beta AXIS SUSTAINS NOTCH1 SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS 79
NOTCH1 Aberrant Activation Is a Common Nonmutational Early Event in Chronic Lymphocytic Leukemia Hematopoietic Stem-Cells 75
NOTCH-1 ACTIVATION AND SUBCLONAL MUTATION NEGATIVELY IMPACT ON CHRONIC LYMPHOCYTIC LEUKEMIA OUTCOMES 74
Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation. 67
NOTCH and Graft-Versus-Host Disease 66
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy. 65
null 37
Pre-test probability determines optimal ANA screening strategy: a risk-stratified comparison of indirect immunofluorescence and CTD screen assay 7
Totale 5.768
Categoria #
all - tutte 25.761
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.761


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022593 0 174 8 21 14 6 9 124 4 55 81 97
2022/2023910 48 169 8 82 75 83 0 45 346 1 35 18
2023/2024441 19 44 27 23 2 17 137 6 16 20 57 73
2024/2025826 41 82 19 43 93 29 44 55 148 43 133 96
2025/20261.883 123 122 85 198 288 201 321 92 198 193 44 18
2026/202792 38 54 0 0 0 0 0 0 0 0 0 0
Totale 5.768